Today: 26 May 2026
Prudential share price hits fresh 12-month high in London — what’s driving PRU and what to watch next
5 January 2026
2 mins read

Prudential share price hits fresh 12-month high in London — what’s driving PRU and what to watch next

LONDON, Jan 5, 2026, 09:48 GMT — Regular session

  • Prudential shares rose 0.9% to 1,165.5 pence by 0932 GMT, after touching 1,169.5 pence in early trade.
  • The stock is up about 86% over the past year, keeping it among the stronger London-listed financial names into the new year.
  • Investors are looking ahead to the group’s full-year results on March 19 and any update on a new share buyback it has flagged for early 2026.

Prudential shares edged higher on Monday, extending a recent rally and pushing the Asia-focused insurer to a fresh 12-month high in London trade. The stock was up 0.9% at 1,165.5 pence by 0932 GMT after earlier hitting 1,169.5 pence, LSEG data showed.

The move matters because Prudential has started 2026 with momentum after an 86% gain over the past year, leaving it sensitive to any shift in risk appetite or fresh signals on capital returns. The early push above last week’s highs also puts technical levels back in focus for short-term investors.

There was no fresh earnings release on Monday, leaving investors to anchor on what comes next: the group’s 2025 full-year results on March 19 and a business performance update scheduled for April 30. A company statement in late December said Prudential intended to begin a further share buyback programme in early 2026.

A London Stock Exchange factsheet compiled by FTSE Russell dated Jan. 2 showed Prudential trading 6.3% above its 50-day moving average and 20.8% above its 200-day moving average. It put the stock’s relative strength index (RSI) at 67.45 — a momentum gauge where readings above 70 are often seen as “overbought,” meaning the rally may be stretched. London Stock Exchange API

Prudential generates most of its business in Asia and Africa, selling life and health insurance and running an asset management arm, with its primary listing in London and a secondary listing in Hong Kong. That footprint leaves the shares exposed to swings in regional sentiment and currency moves alongside global rates.

The company’s most recent routine share-capital update showed it had 2,548,213,779 shares in issue as of Dec. 31, a figure used by investors to calculate notification thresholds under UK rules on disclosing significant shareholdings.

For the March results, investors will focus on new business profit and sales volumes, plus any commentary on margins and capital generation after a sharp move in the shares over the past year. Any detail on the timing and size of the next buyback will likely matter as much as headline profit numbers.

One risk is that the rally runs into profit-taking if markets turn more defensive or if Asia-facing insurers fall out of favour. With momentum indicators already elevated, even a routine update can jolt the shares if guidance or capital-return language disappoints.

In the near term, traders will watch whether the stock can hold above Friday’s close of 1,155 pence and build on Monday’s early push toward the 1,170 pence area. The FTSE Russell factsheet put the 50-day moving average around 1,087 pence and the 200-day near 956 pence, levels some investors use as reference points for trend support.

The next clear catalyst is Prudential’s full-year results on March 19, followed by the April 30 business performance update, with attention also on any announcement of the planned early-2026 buyback.

Stock Market Today

  • AstraZeneca Shares Show Mixed Momentum After Strong 1-Year Gains
    May 26, 2026, 6:09 AM EDT. AstraZeneca (LSE:AZN) shares edged down recently after a robust 35.05% total return over the past year, closing at £139.16. Despite a modest 2.38% gain year-to-date, momentum has cooled prompting investor reassessment of growth and risks. Analysts see a fair value of £163.06, suggesting the stock is about 14.7% undervalued amid expectations of blockbuster drug launches in oncology and other fields potentially generating $10 billion in peak revenue. However, concerns remain around pricing pressures and costly R&D risks that could impact future earnings. Investors are advised to weigh potential rewards against key risks amid this evolving outlook.

Latest articles

Centrica Shares Trade Lower Ahead of Ofgem Announcement

Centrica Shares Trade Lower Ahead of Ofgem Announcement

26 May 2026
Centrica shares fell 0.4% to 199.55p in early London trading Tuesday, lagging the FTSE 100 ahead of Ofgem’s upcoming energy price cap decision. British Gas launched a two-year fixed tariff as markets braced for possible higher bills tied to Gulf tensions and rising wholesale prices. Brent crude rose 3% after U.S. strikes in Iran. Centrica remains about 9.5% below its April high.
Navitas Shares Jump Again, Hot Streak Faces Dilution Risk With AI Bet

Navitas Shares Jump Again, Hot Streak Faces Dilution Risk With AI Bet

26 May 2026
Navitas Semiconductor shares rose to around $32 in premarket trading Tuesday, up 9.4% from Friday’s $29.25 close. Two SEC filings from May 22 detailed the issuance of over 3.2 million merger earnout shares and the settlement of a SPAC-era sponsor share dispute. The company remains unprofitable and has increased its share count under prior agreements. First-quarter revenue reached $8.6 million, down from $14 million a year ago.
BP Shares Edge Lower Despite Oil Gains—Traders Eye Moves

BP Shares Edge Lower Despite Oil Gains—Traders Eye Moves

26 May 2026
BP shares fell 0.6% to 548.0p in late-morning London trade Tuesday, despite Brent crude rising over 2% to $98.21 a barrel after U.S. strikes in Iran. Shell also slipped 0.3%. BP’s net debt rose to $25.3 billion last quarter, and the company paused share buybacks in February to cut debt.
UK Stock Market Open Today: FTSE 100 Futures Near 10,000 as Venezuela Shock Puts Oil and Deals in Focus
Previous Story

UK Stock Market Open Today: FTSE 100 Futures Near 10,000 as Venezuela Shock Puts Oil and Deals in Focus

Brand Engagement Network (BNAI) stock rises again premarket as AI pharma deal keeps traders hooked
Next Story

Brand Engagement Network (BNAI) stock rises again premarket as AI pharma deal keeps traders hooked

Go toTop